Return to homepagePandemic Pact

COVID-19 active surveillance study-3

Grant number: 2014-2020.15.01.22-0162

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2023

  • Known Financial Commitments (USD)

    $4,614,032.46

  • Funder

    Estonian Research Council

  • Principal Investigator

    Jürisson Mikk

  • Research Location

    Estonia

  • Lead Research Institution

    University of Tartu

  • Research Priority Alignment

    N/A

  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease surveillance & mapping

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Health policy is informed by valid and reliable prevalence data. The University of Tartu has initiated a surveillance system for assessing the prevalence of SARS-CoV-2 infection and the level of antibodies in the population. Surveillance enables monitoring of acquired immunity in the population that serves as a basis for an exit strategy and a warning system for the third wave of epidemics.